MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 48 filers reported holding MEI PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12 | -99.7% | 52 | -99.7% | 0.00% | – |
| Q4 2022 | $3,713 | -95.7% | 15,244 | -93.3% | 0.00% | – |
| Q3 2022 | $87,000 | -26.3% | 226,142 | +16.0% | 0.00% | – |
| Q2 2022 | $118,000 | +686.7% | 195,028 | +3494.3% | 0.00% | – |
| Q3 2021 | $15,000 | -6.2% | 5,426 | -30.2% | 0.00% | – |
| Q4 2017 | $16,000 | +6.7% | 7,772 | +43.4% | 0.00% | – |
| Q3 2017 | $15,000 | -95.5% | 5,420 | -97.2% | 0.00% | -100.0% |
| Q2 2015 | $332,000 | -20.0% | 193,860 | -16.4% | 0.01% | -28.6% |
| Q1 2015 | $415,000 | +2493.8% | 231,871 | +6013.1% | 0.01% | – |
| Q4 2014 | $16,000 | +433.3% | 3,793 | +908.8% | 0.00% | – |
| Q3 2014 | $3,000 | -50.0% | 376 | -61.5% | 0.00% | – |
| Q2 2014 | $6,000 | -75.0% | 976 | -55.1% | 0.00% | – |
| Q1 2014 | $24,000 | -55.6% | 2,176 | -67.6% | 0.00% | -100.0% |
| Q4 2013 | $54,000 | -43.8% | 6,722 | -20.8% | 0.00% | -50.0% |
| Q3 2013 | $96,000 | – | 8,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 600,000 | $1,074,000 | 0.22% |
| Iguana Healthcare Management, LLC | 150,000 | $269,000 | 0.11% |
| Endurant Capital Management LP | 95,438 | $171,000 | 0.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,568 | $1,437,000 | 0.05% |
| Opus Point Partners Management, LLC | 30,000 | $54,000 | 0.04% |
| Carnick & Kubik, LLC | 30,355 | $54,000 | 0.04% |
| GREAT POINT PARTNERS LLC | 52,254 | $94,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 296,491 | $531,000 | 0.02% |
| Ancora Advisors LLC | 0 | $146,000 | 0.02% |
| SIMPLEX TRADING, LLC | 70,249 | $125,000 | 0.02% |